315 related articles for article (PubMed ID: 26124721)
1. Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes.
Raunio H; Kuusisto M; Juvonen RO; Pentikäinen OT
Front Pharmacol; 2015; 6():123. PubMed ID: 26124721
[TBL] [Abstract][Full Text] [Related]
2. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.
Hakkola J; Pelkonen O; Pasanen M; Raunio H
Crit Rev Toxicol; 1998 Jan; 28(1):35-72. PubMed ID: 9493761
[TBL] [Abstract][Full Text] [Related]
3. Circulating Extracellular Vesicles Containing Xenobiotic Metabolizing CYP Enzymes and Their Potential Roles in Extrahepatic Cells Via Cell-Cell Interactions.
Gerth K; Kodidela S; Mahon M; Haque S; Verma N; Kumar S
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817878
[TBL] [Abstract][Full Text] [Related]
4. The Central Role of Cytochrome P450 in Xenobiotic Metabolism-A Brief Review on a Fascinating Enzyme Family.
Esteves F; Rueff J; Kranendonk M
J Xenobiot; 2021 Jun; 11(3):94-114. PubMed ID: 34206277
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brain.
Stocco MR; Tyndale RF
Adv Pharmacol; 2022; 95():73-106. PubMed ID: 35953164
[TBL] [Abstract][Full Text] [Related]
6. Effects of cytochrome P450 inhibitors on peroxidase activity.
Martinkova M; Kubickova B; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():33-40. PubMed ID: 23353841
[TBL] [Abstract][Full Text] [Related]
7. Novel Electrotopological Atomic Descriptors for the Prediction of Xenobiotic Cytochrome P450 Reactions.
Kaitoh K; Kotera M; Funatsu K
Mol Inform; 2019 Oct; 38(10):e1900010. PubMed ID: 31187601
[TBL] [Abstract][Full Text] [Related]
8. Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.
Kirchmair J; Williamson MJ; Tyzack JD; Tan L; Bond PJ; Bender A; Glen RC
J Chem Inf Model; 2012 Mar; 52(3):617-48. PubMed ID: 22339582
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
Manikandan P; Nagini S
Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
[TBL] [Abstract][Full Text] [Related]
10. Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas.
Standop J; Ulrich AB; Schneider MB; Büchler MW; Pour PM
Pancreatology; 2002; 2(6):510-8. PubMed ID: 12435863
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach.
Castell JV; Donato MT; Gómez-Lechón MJ
Exp Toxicol Pathol; 2005 Jul; 57 Suppl 1():189-204. PubMed ID: 16092727
[TBL] [Abstract][Full Text] [Related]
12. Interactions of herbs with cytochrome P450.
Zhou S; Gao Y; Jiang W; Huang M; Xu A; Paxton JW
Drug Metab Rev; 2003 Feb; 35(1):35-98. PubMed ID: 12635815
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
[TBL] [Abstract][Full Text] [Related]
14. Prediction of drug metabolism: the case of cytochrome P450 2D6.
Vermeulen NP
Curr Top Med Chem; 2003; 3(11):1227-39. PubMed ID: 12769702
[TBL] [Abstract][Full Text] [Related]
15. The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes.
Mikov M; Đanić M; Pavlović N; Stanimirov B; Goločorbin-Kon S; Stankov K; Al-Salami H
Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):881-890. PubMed ID: 28534261
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination.
Bernauer U; Heinrich-Hirsch B; Tönnies M; Peter-Matthias W; Gundert-Remy U
Toxicol Lett; 2006 Jul; 164(3):278-88. PubMed ID: 16483733
[TBL] [Abstract][Full Text] [Related]
17. Oxidation of 3-aminobenzanthrone, a human metabolite of carcinogenic environmental pollutant 3-nitrobenzanthrone, by cytochromes P450 - similarity between human and rat enzymes.
Mizerovska J; Dracinska H; Arlt VM; Schmeiser HH; Frei E; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():52-9. PubMed ID: 20027145
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.
Salminen KA; Meyer A; Jerabkova L; Korhonen LE; Rahnasto M; Juvonen RO; Imming P; Raunio H
Phytomedicine; 2011 Apr; 18(6):533-8. PubMed ID: 20851588
[TBL] [Abstract][Full Text] [Related]
19. The Cytochrome P450 Enzymes of Hepatic Drug Metabolism: How are their Activities Assessed In Vivo, and what is their Clinical Relevance?
Bachmann KA
Am J Ther; 1996 Feb; 3(2):150-171. PubMed ID: 11859386
[TBL] [Abstract][Full Text] [Related]
20. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues.
Pavek P; Dvorak Z
Curr Drug Metab; 2008 Feb; 9(2):129-43. PubMed ID: 18288955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
